Improving cancer communication to patients

September 19, 2011 in Cancer

Oncologists and their patients are increasingly challenged with making difficult decisions about screening, prevention and treatment. Unfortunately, most patients are neither armed with adequate knowledge nor the means of interpreting the information they do have in a qualitatively and quantitatively useful way.

In a commentary published Sept. 19 in the Journal of the , Angela Fagerlin, Ph.D., of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan and the VA Ann Arbor Center for Research, and colleagues highlight 10 recommendations for improved communication to patients.

These methods have been shown to improve patients' understanding of the information they are presented with when asked to make important decisions.

The authors first outline typical problems that arise when physicians must present complex medical information to patients and break it down in simple terms. Patients often don't have the needed to understand what their doctors say to them and have difficulty grasping the reading materials they obtain through the . Patients also tend to lack the numeracy skills needed to comprehend useful statistics such as risk and benefit statistics.

The researchers recommend that doctors use to make their written and verbal materials more understandable and present only information that is relevant to patients. They also say the order of presenting types of information is important: citing the "recency effect," which shows that patients better remember the most recent information presented to them.

Presenting information in terms of absolute risks (the specific chances of developing the disease under different circumstances) rather than relative risks (e.g., "50% greater risk") is another strategy the researchers recommend.

Research has shown that when relative risk is used, risk reduction appears larger and treatments are viewed more favorably, which can inappropriately lead patients and physicians to choose treatments, they write. The authors also urge doctors to always emphasize the element of time, because patients may make different decisions based on the time period presented. For example, presenting a patient's lifetime risk (e.g., instead of the risk within a ten-year interval) can lead to different perception of the risk in a patient's mind.

In their summary, the authors point out that their commentary is not a systematic review of the literature but focuses on some of the most commonly accepted recommendations for risk communication. They write, "We believe it is the responsibility of all cancer educators, decision aid developers, and clinicians to be familiar with the growing body of rigorous research that has tested effective methods of presenting probabilistic information, so that can use it to make an informed decision."

Provided by Journal of the National Cancer Institute search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 1 hour ago | popularity not rated yet | comments 0

Racial disparities in the surgical management of non-small cell lung cancer

The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

Cancer created 5 hours ago | popularity not rated yet | comments 0

Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency

Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...

Cancer created 5 hours ago | popularity not rated yet | comments 0

New tumour-killer shows great promise in suppressing cancers

Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.

Cancer created 5 hours ago | popularity 5 / 5 (1) | comments 0

New factor to control oncogene-induced senescence

An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...

Cancer created 6 hours ago | popularity not rated yet | comments 0


Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

Decisions to forgo life support may depend heavily on the ICU where patients are treated

The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...

Better behavior after tonsil/adenoid surgery for kids with sleep breathing trouble?

Children with obstructive sleep apnea who had a common surgery to remove their tonsils and adenoids showed notable improvements in behavior, quality of life and other symptoms compared to those treated with "watchful waiting" ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.